News Focus
News Focus
icon url

Whalatane

02/01/21 12:33 AM

#322626 RE: dmlcento #322606

DML. In early Nov I posted why I was buying AMRN .
Last Friday I posted why I was selling half that Nov position ....I was up 80% which is fine with me .
Tonite I’m trying to share what IMHO is the importance of Kaiser’s MITIGATE COVID trial . RAF provided the Twitter link

IF ....again ..IF , the interim data on this trial ....due late Feb / March indicates Vascepa is likely to reduce COVID hospitalization by those studied ( high risk CAD patients ) by more then 18% .....it will be the biggest thing since the Reduce It trial data release .....provided it’s confirmed in final analysis at the end of the trial .
That is just my opinion
Don’t know if it’s “ self serving “ or not .
Do your own DD and make your own decision.
This post is not intended as investment advice
We clear now ?
Kiwi
icon url

postes

02/01/21 12:39 AM

#322627 RE: dmlcento #322606

Dmlcento..this a man that tried to castrate Marjac last year and would not apologize or back off.
icon url

Whalatane

02/01/21 12:38 PM

#322753 RE: dmlcento #322606

DML. Be fore warned. I’ll probably be writing some self serving posts on the MITIGATE trial later today .

I’ve decided to buy some AMRN late March and April call options on what I hope will be great interim results .

I’m not suggesting anyone do likewise. I usually lose buying options .
My MITIGATE posts will be an endeavor to get others to find holes in my expectation that if interim is very positive it will be a game changer for AMRN

Feel free to challenge my MITIGATE hypothesis .
I welcome opposing views
Kiwi